Kaplan–Meier analysis comparing new DUs free survival in SSc patients with increase in resistin serum level demonstrated that those with resistin serum level > 12.1 ng/ml develop new DUs (LogRank = 0.002) (Fig. 1). This evidence concerns the gene RETN and systemic sclerosis.